ProCE Banner Activity

Graft-vs-Host Disease Management in the Modern Era: Expert Insights on Incorporating Recent Advances Into Care

Slideset Download
Download these slides with expert recommendations on the management of patients with acute and chronic graft versus host disease (GVHD) after transplantation.

Released: April 13, 2020

Expiration: April 12, 2021

No longer available for credit.

Share

Faculty

Corey Cutler

Corey Cutler, MD, MPH, FRCPC

Associate Professor of Medicine
Harvard Medical School
Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Incyte

Pharmacyclics Inc

Faculty Disclosure

Primary Author

Corey Cutler, MD, MPH, FRCPC

Associate Professor of Medicine
Harvard Medical School
Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, Massachusetts

Corey S. Cutler MD, MPH, FRCPC, has disclosed that he has received consulting fees from Elsalys, Fresenius Kabi, Genentech, Generon, Incyte, Jazz, Kadmon, Medsenic, Omeros, and Pharmacyclics.